8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.27%
Negative revenue growth while 3141.T stands at 3.12%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.56%
Negative gross profit growth while 3141.T is at 4.80%. Joel Greenblatt would examine cost competitiveness or demand decline.
-25.71%
Negative EBIT growth while 3141.T is at 18.41%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-29.63%
Negative operating income growth while 3141.T is at 26.01%. Joel Greenblatt would press for urgent turnaround measures.
-26.28%
Negative net income growth while 3141.T stands at 17.94%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-26.27%
Negative EPS growth while 3141.T is at 17.90%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-26.27%
Negative diluted EPS growth while 3141.T is at 18.04%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share change of 0.00% while 3141.T is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.93%
10Y revenue/share CAGR under 50% of 3141.T's 126.68%. Michael Burry would suspect a lasting competitive disadvantage.
66.65%
5Y revenue/share CAGR at 75-90% of 3141.T's 83.45%. Bill Ackman would encourage strategies to match competitor’s pace.
33.46%
3Y revenue/share CAGR at 75-90% of 3141.T's 37.48%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.85%
Below 50% of 3141.T's 745.23%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
40.83%
Below 50% of 3141.T's 137.11%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-8.53%
Negative 3Y CAGR while 3141.T is 38.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
126.08%
5Y equity/share CAGR above 1.5x 3141.T's 81.45%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.09%
3Y equity/share CAGR above 1.5x 3141.T's 38.61%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-9.09%
Negative 5Y dividend/share CAGR while 3141.T stands at 183.08%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
42.86%
3Y dividend/share CAGR at 50-75% of 3141.T's 84.00%. Martin Whitman might see a weaker short-term approach to distributing cash.
67.36%
AR growth well above 3141.T's 18.42%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.88%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.82%
Asset growth well under 50% of 3141.T's 9.10%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.86%
50-75% of 3141.T's 4.43%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-4.54%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
2.21%
SG&A growth well above 3141.T's 1.69%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.